Literature DB >> 8075268

Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae.

M J Catalán1, J M Fernández, A Vazquez, E Varela de Seijas, A Suárez, J C Bernaldo de Quirós.   

Abstract

To our knowledge, we report the first failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae (MICs of penicillin and cefotaxime, 1 microgram/mL). Cure was achieved with a 14-day course of intravenous and intrathecal vancomycin. We recommend that in cases of meningitis caused by strains of S. pneumoniae for which MICs are > or = 1 microgram/mL, cefotaxime should be used with caution; however, if therapeutic failure is suspected therapy should be changed to intravenous and intrathecal vancomycin.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8075268     DOI： 10.1093/clinids/18.5.766

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Description of two new isolates of Streptococcus pneumoniae in spain that are highly resistant to cefotaxime.

Authors:  J Ruiz; M Sempere; E Simarro; A Fenoll
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

3.  Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Authors:  K Tateda; K Takashima; H Miyazaki; T Matsumoto; T Hatori; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

4.  Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.

Authors:  Penny Crowther-Gibson; Cheryl Cohen; Keith P Klugman; Linda de Gouveia; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.

Authors:  B Barry; M Muffat-Joly; J Bauchet; F Faurisson; P Gehanno; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; N Peyrard; A Pechinot; M Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.

Authors:  I Lutsar; A Ahmed; I R Friedland; M Trujillo; L Wubbel; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

8.  Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.

Authors:  A L Barry; P C Fuchs
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 9.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitis.

Authors:  Shin-Woo Kim; Joung Hwa Jin; Soo Jung Kang; Sook-In Jung; Yeon-Sook Kim; Choon-Kwan Kim; Hyuck Lee; Won Sup Oh; Sungmin Kim; Kyong Ran Peck; Jae-Hoon Song
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.